QTOP iShares Nasdaq Top 30 Stocks ETF

Expense Ratio
0.2%
Dividend
0.41%
Previous close
$30.42
Est. 12 months change
+24.43%
Projected Price
$37.85

Profitability Metrics

Return on Equity (ROE)
51.47%
Return on Assets (ROA)
16.95%
Return on Invested Capital (ROIC)
49.93%
Weighted Average Cost of Capital (WACC)
11.28%
ROIC - WACC
38.66%
Updated : 2026-04-04 08:25 ET

Valuation Metrics

P/E Ratio
33.86
Forward P/E
22.79
PEG Ratio
2.05
Debt Current Ratio
2.10

Growth & Cash Flow

Gross Margin
55.61%
Operating Margin
31.04%
FCF Margin
23.13%
TTM Revenue Growth
27.96%
Projected 12M EPS Growth
48.59%

Price Change

Price % from 50 SMA
-2.66%
Price % from 200 SMA
-1.23%
6 Months
-2.71%
1 Year
26.12%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA11.41%
AAPL10.24%
MSFT7.43%
AMZN6.00%
WMT4.72%
GOOGL4.47%
TSLA4.41%
GOOG4.17%
AVGO4.09%
META3.98%

ETF Analysis

Fund Overview

iShares Nasdaq Top 30 Stocks ETF (QTOP) currently reports 30 stock positions (subject to change), placing it in the mid-range in diversification range by holdings breadth. The top line-up is NVDA (11.41%), AAPL (10.24%), MSFT (7.43%), with NVDA as the largest single weight at 11.41%. Together, the top three holdings account for 29.08%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 49.93%, WACC is 11.28%, and the economic spread is 38.66%. On balance, the economic spread here is exceptional — few portfolios sustain this kind of gap between operating returns and cost of capital. Supporting metrics show ROE at 51.47% and ROA at 16.95%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 33.86, forward P/E of 22.79, PEG of 2.05. The gap between trailing and forward multiples is wide, suggesting the market is pricing meaningful earnings expansion over the coming year. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. The aggregate current ratio of 2.10 reflects a holding set with workable near-term liquidity positions. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 55.61%, operating margin at 31.04%, and free cash flow margin at 23.13%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The portfolio's operating margins are well above average, pointing to businesses that manage the full cost stack with discipline. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. Taken together, the margin profile reflects a collection of businesses with genuine competitive advantages — capable of sustaining profitability and generating cash across a range of economic conditions.

Growth & Forward Outlook

Combining revenue momentum with analyst targets, the estimated 12-month price change of 24.68%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 27.96% reflecting top-line acceleration that, if sustained, supports the forward earnings case. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

When all the evidence is placed side by side, this profile stands out as one with genuine compounding characteristics and limited structural headwinds.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.